Breast Neoplasms  >>  utidelone IV (UTD1)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
utidelone IV (UTD1) / Beijing Biostar Technologies
NCT02253459: Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer

Completed
3
405
RoW
UTD1 Injection plus capecitabine, Capecitabine
Beijing Biostar Technologies, Ltd
Breast Cancer
09/16
12/18

Download Options